Song et al.
21.0, 22.5, 22.8, 23.1, 23.8, 24.1, 25.8, 26.2, 27.9, 28.2, 29.2, 32.8,
35.5, 35.7, 35.9, 36.1, 36.6, 39.4, 40.0, 41.0, 42.6, 43.7, 45.4, 56.3,
56.4, 124.0, 168.6, 199.8 (30 of 31 expected resonances); MS (EI)
m/z 438 (M+, 52), 423 (M - CH3, 19), 316 (37), 81 (100); exact
mass 438.3876, calcd for C31H50O 438.3862.
indicate that large, propeller-like guests should fit easily into
the clefts. For this reason, cocrystallization experiments with
triphenylphosphine, triphenylamine, tris(pentafluorophenyl)-
phosphine, and tris(pentafluorophenyl)borane were attempted,
but without success. Whether these molecules associate with
the supertristeroids in solution is the subject of future experi-
ments.
2R,3â- (8) and 2R,3R-(3′-Oxocyclohexano)-5â-cholestane (9)
by Hydrogenation of 7. Pentacyclic ketone 7 (70 mg, 0.16 mmol)
was dissolved in ethanol (20 mL), and 10% Pd on C (10 mg) was
added. The mixture was hydrogenated for 1 h at 45 psi. The catalyst
was filtered away, and the solvent was removed to give a colorless
solid. Silica gel column chromatography (solvent, 30:1 hexanes/
ether) gave two new pentacyclic ketones. Compound 8 (35 mg,
0.080 mmol, 50%) eluted first, followed by compound 9 (28 mg,
0.064 mmol, 40%). Subsequent X-ray analysis established the
structures of 8 and 9 as the 2R,3â (trans) and 2R,3R (cis) isomers,
respectively. Compound 8: mp 120-122 °C; 1H NMR (CDCl3) δ
0.65 (s, 3H), 0.86 (d, J ) 7 Hz, 6H), 0.90 (d, J ) 7 Hz, 3H), 0.95
(s, 3H), 0.99-1.70 (methylene envelope, 24H), 1.85 (m, 4H), 2.00
(d, J ) 12 Hz, 1H), 2.10 (t, J ) 14 Hz, 1H), 2.36 (m, 3H); 13C
NMR (CDCl3) δ 12.0, 18.7, 20.9, 22.5, 22.8, 23.8, 23.9, 24.2, 26.5,
26.9, 28.0, 28.3, 33.6, 35.0, 35.8, 35.9, 36.0, 36.2, 39.5, 40.3, 41.6,
41.7, 42.7, 42.8, 43.8, 44.0, 48.3, 56.4, 56.6, 211.8 (30 of 31
expected resonances); MS (EI) m/z 440 (M+, 29), 425 (M - CH3,
60), 285 (100); exact mass 440.4020, calcd for C31H52O 440.4018.
Compound 9: mp 155-157 °C; 1H NMR (CDCl3) δ 0.65 (s, 3H),
0.87 (d, J ) 7 Hz, 6H), 0.89 (d, J ) 7 Hz, 3H), 1.01 (s, 3H),
0.95-2.03 (methylene envelope, 32H), 2.20 (m, 3H), 2.37 (td, J
) 14, 7 Hz, 1H), 2.66 (t, J ) 14 Hz, 1H); 13C NMR (CDCl3) δ
12.0, 18.7, 20.8, 22.5, 22.8, 23.8, 24.2, 24.4, 26.4, 26.5, 28.0, 28.3,
28.5, 31.7, 31.8, 35.5, 35.77, 35.81, 36.2, 36.6, 36.8, 38.0, 39.5,
40.2, 40.7, 42.4, 42.7, 56.4, 56.6, 213.3 (30 of 31 expected
resonances); MS (EI) m/z 440 (M+, 27), 425 (M - CH3, 58), 285
(100); exact mass 440.4003, calcd for C31H52O 440.4018.
2R,3â-(3′-Oxocyclohexano)-5â-cholestane (8) by Li/NH3 Re-
duction of 7. Lithium (23 mg, 3.3 mmol) was added to liquid
ammonia (∼25 mL) in a three-necked flask topped by a dry ice
condenser and a CaCl2 drying tube. After the solution turned dark
blue, a solution of pentacyclic ketone 7 (180 mg, 0.411 mmol) in
THF (2 mL) was added over 1 h. The solution was stirred for
another 2 h, and then solid NH4Cl was added to quench the reaction.
After the ammonia had evaporated, water was added, and the
mixture was extracted three times with CH2Cl2. The combined
organic layers were washed successively with water, saturated
NaHCO3, and brine, and then dried over Na2SO4. The solution was
concentrated to dryness, and the residue was purified by silica gel
column chromatography to give compound 8 (90 mg, 50%),
identical to that prepared by hydrogenation of 7.
Conclusion
We have reported very short syntheses (3-4 steps) of two
large (C93), chiral, hydrocarbon clefts, containing C3-symmetric
cavities big enough to accommodate guests of moderate
complexity. If one employed a similar synthetic strategy with
precursors containing polar functionalitysperhaps an A/B-cis-
fused polyhydroxy steroid such as cholic acidsthen chiral clefts
with multiple, internally directed polar groups might be prepared.
Experimental Section
Coprostanone (5â-cholestan-3-one), mp 56-58 °C (lit.17 60-
61 °C) was prepared by the method of Forsek.13
2-Hydroxymethylene-5â-cholestan-3-one (6). Sodium (247 mg,
10.7 mmol) and ethyl formate (0.89 mL, 10.7 mmol) were added
to a solution of coprostanone (2.08 g, 5.37 mmol) in dry ether (40
mL). The flask was placed in an ice bath, the reaction was initiated
by the addition of ethanol (0.4 mL), and the mixture was stirred
overnight. Ethanol was added to destroy any excess sodium, and
after stirring for 0.5 h, water and 3 N HCl were added. The acidic
solution was extracted three times with ether. The combined organic
layers were washed twice with brine, dried over Na2SO4, and
concentrated to give compound 6 (2.21 g, 5.33 mmol, 99%): mp
1
98-100 °C; H NMR (CDCl3) δ 0.63 (s, 3H), 0.84 (d, J ) 7 Hz,
6H), 0.86 (d, J ) 7 Hz, 3H), 1.03 (s, 3H), 0.90-1.99 (methylene
envelope, 26H), 2.29 (dd, J ) 20, 8 Hz, 1H), 2.32 (d, J ) 16 Hz,
1H), 2.52 (dd, J ) 20, 10 Hz, 1H), 8.24 (s, 1H), 14.31 (br s, 1H);
13C NMR (CDCl3) δ 12.0, 18.6, 20.9, 22.2, 22.5, 22.8, 23.7, 24.1,
25.2, 25.3, 27.9, 28.2, 33.8, 34.7, 35.06, 35.14, 35.7, 36.0, 38.4,
39.4, 39.8, 40.4, 42.6, 56.1, 56.2, 107.3, 181.7, 189.3 (28 of 28
expected resonances); MS (EI) m/z 414 (M+, 10), 386 (M - CO,
22), 316 (53), 81 (100); exact mass 414.3494, calcd for C28H46O2
414.3498.
2R,3-(3′-Oxocyclohex-4′-eno)-5â-cholestane (7). Triethylamine
(2.2 mL, 15.3 mmol) and methyl vinyl ketone (1.9 mL, 23 mmol)
were added to a solution of ketone 6 (1.58 g, 3.82 mmol) in ethyl
acetate (20 mL). Two pellets of solid KOH were then added, and
the reaction mixture was stirred under argon for 24 h at room
temperature. Water was added, and the mixture was acidified to
pH 2 with 3 N HCl. The aqueous mixture was extracted four times
with ether, and the combined organics were washed three times
with brine. After drying over Na2SO4, removal of the solvent gave
a sticky, yellow solid (the crude initial Michael adduct). This
material was dissolved in a 1:1 mixture of THF and 6 N HCl (48
mL), and the solution was heated at reflux for 2 h. After cooling,
water was added, and the resulting mixture was extracted three times
with CH2Cl2. The combined organic layers were washed three times
with water, and the combined aqueous layers were back extracted
with CH2Cl2. The combined organics were then washed twice with
brine, dried over Na2SO4, and concentrated to give a yellow oil.
Purification of this material by silica gel column chromatography
(solvent, 10:1 hexanes/ethyl acetate) gave pentacyclic ketone 7 (545
4R,3-(3′-Oxocyclohex-4′-eno)-5â-cholestane (10). Coprostanone
(1.38 g, 3.58 mmol) was subjected to the same two-step procedure
used for the preparation of compound 7 from 6. The crude cyclized
product was purified by preparative TLC (solvent, 10:1 hexanes/
ethyl acetate) to give pure compound 10 (549 mg, 1.25 mmol,
1
35%): mp 82-85 °C; H NMR (CDCl3) δ 0.64 (s, 3H), 0.84 (d,
J ) 7 Hz, 6H), 0.88 (d, J ) 7 Hz, 3H), 0.96 (s, 3H), 1.20-2.43
(methylene envelope, 33H), 2.65 (t, J ) 9 Hz, 1H), 5.82 (s, 1H);
13C NMR (CDCl3) δ 12.0, 18.6, 21.1, 22.0, 22.5, 22.7, 23.6, 23.7,
24.0, 25.6, 27.2, 27.9, 28.2, 30.6, 35.1, 35.5, 35.67, 35.71, 36.0,
36.7, 36.9, 39.4, 40.0, 41.7, 42.6, 50.3, 56.2, 56.4, 124.5, 168.6,
199.9 (31 of 31 expected resonances); MS (EI) m/z 438 (M+, 79),
423 (M - CH3, 36), 329 (47), 175 (100); exact mass 438.3867,
calcd for C31H50O 438.3862.
4R,3â- (11) and 4R,3R-(3′-Oxocyclohexano)-5â-cholestane (12)
by Hydrogenation of 10. Pentacyclic ketone 10 (90 mg, 0.21
mmol) was hydrogenated and fractionated as described for the
preparation of compounds 8 and 9, to give the saturated ketones
11 (42 mg, 0.095 mmol, 45%) and 12 (37 mg, 0.084 mmol, 40%).
Subsequent X-ray analysis established the structure of 11 as the
1
mg, 1.24 mmol, 33%): mp 84-87 °C; H NMR (CDCl3) δ 0.66
(s, 3H), 0.86 (d, J ) 7 Hz, 6H), 0.90 (d, J ) 7 Hz, 3H), 0.98 (s,
3H), 1.01-2.07 (methylene envelope, 30H), 2.37 (m, 3H), 2.75 (t,
J ) 14 Hz, 1H), 5.83 (s, 1H); 13C NMR (CDCl3) δ 12.0, 18.6,
1
4R,3â (trans) isomer. Compound 11: mp 125-127 °C; H NMR
(17) Rubin, M.; Armbrecht, B. H. J. Am. Chem. Soc. 1953, 75, 3513-
3516.
(CDCl3) δ 0.65 (s, 3H), 0.86 (d, J ) 7 Hz, 6H), 0.90 (d, J ) 7 Hz,
4452 J. Org. Chem., Vol. 72, No. 12, 2007